InsiderTrades

Form 4 for ACRS Aclaris Therapeutics, Inc.

Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001209191-24-002838 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-05 2024-02-01 ACRS Loerop James Chief Business Off M - OptEx — +18.8K 32.9K +132% —
DM 2024-02-05 2024-02-01 ACRS Loerop James Chief Business Off F - Tax $1.20 -6,421 29.1K -18% -$7,705
DM 2024-02-05 2024-02-01 ACRS Loerop James Chief Business Off M - OptEx $0.00 -18.8K 22.5K -45% $0
DM 2024-02-05 2024-02-01 ACRS Loerop James Chief Business Off A - Grant $0.00 +413.0K 59.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-01 M A 7,500 — 36,585 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
2 Common Common Stock 2024-02-01 F D 2,568 $1.20 34,017 D — —
3 Common Common Stock 2024-02-01 M A 11,250 — 32,938 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
4 Common Common Stock 2024-02-01 F D 3,853 $1.20 29,085 D — —
5 Derivative Restricted Stock Unit 2024-02-01 M D 7,500 $0.00 22,500 D — · — to — 7,500 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F4) The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
6 Derivative Employee Stock Option (Right to Buy) 2024-02-01 A A 206,500 $0.00 206,500 D $1.20 · — to 2034-01-31 206,500 Common Stock (F5) Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
7 Derivative Restricted Stock Units 2024-02-01 A A 147,500 $0.00 147,500 D — · — to — 147,500 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F7) 50% of the shares underlying these restricted stock units vest on each of December 31, 2024 and December 31, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
8 Derivative Restricted Stock Units 2024-02-01 M D 11,250 $0.00 22,500 D — · — to — 11,250 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F3) The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2022, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
9 Derivative Restricted Stock Units 2024-02-01 A A 59,000 $0.00 59,000 D — · — to — 59,000 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F6) The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.